Business ExpandingProdrome Sciences Establishes Japanese Subsidiary to Advance Global Health Initiatives Bridging Science and Community Care

Founded in 2016 in California, USA, Prodrome Sciences is guided by the vision of achieving Perpetual Health—a state of sustained wellness through science-based metabolic analysis and nutritional support. The company aims to prevent disease and extend healthy lifespan by identifying and addressing early metabolic changes.

Prodrome Sciencesprovides blood-based lipid profiling services and plasmalogen^* -centered nutritional interventions. These offerings support medical professionals, researchers, and consumers through education, research collaboration, and personalized health strategies. In North America, the company actively engages in Community Health initiatives and charity programs for rare diseases, contributing to public health and social impact.

To support its expansion into the Japanese market, Prodrome Japan Inc. was established in Osaka. The company received assistance from the JETRO through its Invest Japan Business Support Center (IBSC), including consultations on registration, taxation, and labor, guidance from industry-specific advisors (ADH), and access to IBSC’s temporary office facilities.

*: Plasmalogens are a class of phospholipids found abundantly in the brain, nervous system, and immune cells. Their levels are known to decline with age and disease. Recent research has highlighted their potential relevance to cognitive function and neurodegenerative conditions, making them a focus of preventive nutritional strategies.